Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management
- 1st Edition - October 1, 2026
- Latest edition
- Editor: Wael Mohamed
- Language: English
Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management offers a comprehensive exploration of the latest innovations and multidisciplinary approaches i… Read more
Description
Description
Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management offers a comprehensive exploration of the latest innovations and multidisciplinary approaches in Parkinson’s Disease treatment. The volume is organized into sections covering genetic therapies, gut microbiota, artificial intelligence, virtual reality, neuroprotective strategies, polypharmacy, and combination therapies. It addresses the integration of personalized medicine, neuroprotective diets, natural products, cognitive enhancers, and ethical considerations. Additional chapters introduce traditional medicine, music therapy, and the synergy between pharmacotherapy and complementary modalities. The book equips readers with the knowledge to implement innovative therapies, navigate complex ethical landscapes, and integrate multidisciplinary and complementary approaches.
This reference is essential for those seeking to advance clinical practice and research in Parkinson’s Disease through the adoption of cutting-edge strategies.
This reference is essential for those seeking to advance clinical practice and research in Parkinson’s Disease through the adoption of cutting-edge strategies.
Key features
Key features
- Highlights advanced and integrative therapeutic strategies for Parkinson’s Disease management
- Examines multidisciplinary and complementary approaches to care
- Addresses ethical and practical challenges of novel translational therapies
- Discusses future directions for personalized care
Readership
Readership
Neurology and movement disorder clinicians
Table of contents
Table of contents
Section I: Advanced & Precision Therapies
1. Genetic Therapies for Parkinson’s Disease: The Dawn of Precision Medicine
2. Role of Gut Microbiota in Parkinson’s Disease Pharmacotherapy
3. Artificial Intelligence, Machine Learning, Virtual Reality & Gamification in Drug Development
4. rTMS as an Adjunct to Pharmacotherapy
5. Neuroprotective Therapies
6. Polypharmacy and Combination Therapies
Section II: Integration, Cognition & Future Horizons
7. Repurposing Existing Drugs for Parkinson’s Disease Management
8. Personalized Medicine in Parkinson’s Disease
9. Neuroprotective Diets & Synergy with Pharmacotherapy
10. Natural Products in Parkinson’s Disease Animal Models
11. Cognitive Enhancers in Parkinson’s Disease
12. Emerging Targets for Cognitive Enhancement
13. Ethical & Practical Challenges with Cognitive Enhancers
14. Unani Pharmacotherapy in Parkinson’s Disease
15. Music Therapy & Its Synergy with Pharmacotherapy
1. Genetic Therapies for Parkinson’s Disease: The Dawn of Precision Medicine
2. Role of Gut Microbiota in Parkinson’s Disease Pharmacotherapy
3. Artificial Intelligence, Machine Learning, Virtual Reality & Gamification in Drug Development
4. rTMS as an Adjunct to Pharmacotherapy
5. Neuroprotective Therapies
6. Polypharmacy and Combination Therapies
Section II: Integration, Cognition & Future Horizons
7. Repurposing Existing Drugs for Parkinson’s Disease Management
8. Personalized Medicine in Parkinson’s Disease
9. Neuroprotective Diets & Synergy with Pharmacotherapy
10. Natural Products in Parkinson’s Disease Animal Models
11. Cognitive Enhancers in Parkinson’s Disease
12. Emerging Targets for Cognitive Enhancement
13. Ethical & Practical Challenges with Cognitive Enhancers
14. Unani Pharmacotherapy in Parkinson’s Disease
15. Music Therapy & Its Synergy with Pharmacotherapy
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 1, 2026
- Language: English
About the editor
About the editor
WM
Wael Mohamed
Dr. Wael Mohamed is Professor of Basic Medical Science at the International Islamic University Malaysia. He obtained his MD and MSc in Clinical Pharmacology from Meoufia Medical School, Egypt, and his PhD in Neuroscience from The Pennsylvania State University. After finishing his neurosurgery training, he began his career as a clinical pharmacologist with psychopharmacology as a subspecialty. Dr. Mohamed specializes in translational brain research; his current focal area is the investigation and development of novel treatments for Parkinson’s Disease and related neurodegenerative disorders. He is a member of several neuroscience societies, including the American Psychological Association, The Society for Neuroscience, National Academy of Neuropsychology, and the International Congress of Neuropsychopharmacology. He has published several books with Elsevier, including Translational Models of Parkinson’s Disease and Related Movement Disorders, Essential Guide to Neurodegenerative Disorders, and Telehealth in Movement Disorders.
Affiliations and expertise
Basic Medical Science Department Kulliyyah of Medicine, International Islamic University of Malaysia, Pahang, Malaysia